Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021

Kamal Abu Jabal; Hila Ben-Amram; Karine Beiruti; Yunis Batheesh; Christian Sussan; Salman Zarka; Michael Edelstein

doi:10.2807/1560-7917.ES.2021.26.6.2100096

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021

Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti, Yunis Batheesh, Christian Sussan, Salman Zarka, Michael Edelstein

Research output: Contribution to journal › Article › peer-review

Abstract

The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.

Original language	English
Journal	Eurosurveillance
Volume	26
Issue number	6
DOIs	https://doi.org/10.2807/1560-7917.ES.2021.26.6.2100096
State	Published - Feb 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2021 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

ASJC Scopus subject areas

Epidemiology
Public Health, Environmental and Occupational Health
Virology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2807/1560-7917.ES.2021.26.6.2100096

Fingerprint

Dive into the research topics of 'Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021'. Together they form a unique fingerprint.

Cite this

Jabal, K. A., Ben-Amram, H., Beiruti, K., Batheesh, Y., Sussan, C., Zarka, S., & Edelstein, M. (2021). Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Eurosurveillance, 26(6). https://doi.org/10.2807/1560-7917.ES.2021.26.6.2100096

@article{b37b020aafbc4d048370f4e0a563d819,

title = "Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021",

abstract = "The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than na{\"i}ve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.",

author = "Jabal, {Kamal Abu} and Hila Ben-Amram and Karine Beiruti and Yunis Batheesh and Christian Sussan and Salman Zarka and Michael Edelstein",

year = "2021",

month = feb,

doi = "10.2807/1560-7917.ES.2021.26.6.2100096",

language = "English",

volume = "26",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "6",

}

Jabal, KA, Ben-Amram, H, Beiruti, K, Batheesh, Y, Sussan, C, Zarka, S & Edelstein, M 2021, 'Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021', Eurosurveillance, vol. 26, no. 6. https://doi.org/10.2807/1560-7917.ES.2021.26.6.2100096

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021. / Jabal, Kamal Abu; Ben-Amram, Hila; Beiruti, Karine et al.
In: Eurosurveillance, Vol. 26, No. 6, 02.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine

T2 - Real-world evidence from healthcare workers, Israel, December 2020 to January 2021

AU - Jabal, Kamal Abu

AU - Ben-Amram, Hila

AU - Beiruti, Karine

AU - Batheesh, Yunis

AU - Sussan, Christian

AU - Zarka, Salman

AU - Edelstein, Michael

PY - 2021/2

Y1 - 2021/2

N2 - The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.

AB - The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.

UR - http://www.scopus.com/inward/record.url?scp=85101491993&partnerID=8YFLogxK

U2 - 10.2807/1560-7917.ES.2021.26.6.2100096

DO - 10.2807/1560-7917.ES.2021.26.6.2100096

M3 - Article

C2 - 33573712

AN - SCOPUS:85101491993

SN - 1025-496X

VL - 26

JO - Eurosurveillance

JF - Eurosurveillance

IS - 6

ER -

Jabal KA, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S et al. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Eurosurveillance. 2021 Feb;26(6). doi: 10.2807/1560-7917.ES.2021.26.6.2100096

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this